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Abstract The peptide somatostatin-14 (SRIF) acts in the
mammalian retina through its distinct receptors (sst1–5).
Scarce information is available on SRIF function in the
retina, including the elucidation of transduction pathways
mediating SRIF action. We have investigated SRIF and
SRIF receptor modulation of adenylyl cyclase (AC)
activity in both wild-type (WT) retinas and sst1 or sst2
knock-out (KO) retinas, which are known to over-express
sst2 or sst1 receptors respectively. In WT retinas,
application of SRIF compounds does not affect forsko-
lin-stimulated AC activity. In contrast, activation of sst1 or
sst2 receptors inhibits AC in the presence of sst2 or sst1
receptor antagonists respectively. Results from sst1 KO
retinas demonstrate that either SRIF or the sst2 receptor
preferring agonist octreotide, pertussis toxin-dependently
inhibit AC activity. In contrast, in sst2 KO retinas, neither
SRIF nor CH-275, an sst1 receptor agonist, are found to
influence AC activity. As revealed by immunoblotting
experiments, in sst1 KO retinas, levels of Goα proteins are
60% higher than in WT retinas and this increase in Goα
protein levels is concomitant with an increase in sst2A
receptor expression. We conclude that interactions be-
tween sst1 and sst2 receptors may prevent SRIF effects on
AC activity. In addition, we suggest that the density of sst2
receptors and/or Goα proteins may represent the rate-
limiting factor for the sst2 receptor-mediated inhibition of
AC.
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Introduction
Somatostatin-14 (somatotropin release-inhibiting factor,
SRIF) is a neuropeptide widely distributed in the
mammalian nervous system. SRIF exerts its functions by
interacting with plasma membrane receptors. Five G
protein-coupled SRIF receptors have been cloned and
termed sst1 through sst5 receptors (Weckbecker et al.
2003).
Somatostatin-14 and its receptors are also found in the
mammalian retina (Bagnoli et al. 2003). In the mouse
retina, for instance, sparse-occurring amacrine cells
contain SRIF and express sst1 receptors (Cristiani et al.
2002; Dal Monte et al. 2003b). Specific binding for sst2
receptors has been also shown in the mouse retina (Dal
Monte et al. 2003b). In particular, of the two sst2 receptor
isoforms (sst2A and sst2B), the sst2A isoform is expressed
by rod bipolar, by horizontal and by amacrine cells
including dopaminergic amacrine cells (Cristiani et al.
2002; Dal Monte et al. 2003a, 2003b). The sst2B isoform
has been localised by Vasilaki et al. (2001) to photore-
ceptor outer segments in the rat retina in which, on the
other hand, Johnson et al. (1999) have not detected sst2B
receptor mRNA. Finally, the sst4 receptor is in sparse
ganglion cells of the mouse retina, whereas low to very
low levels of sst3 and sst5 receptor mRNAs were detected
(Cristiani et al. 2002).
Although possible involvement of SRIF in retinal
diseases has become recent interest (Thermos 2003),
only little information is available on SRIF function in the
retina. Findings to date suggest that SRIF acts on multiple
retinal circuits to produce long-lasting changes in ganglion
cell activity and receptive field organisation (Zalutsky and
Miller 1990). There is also evidence indicating that SRIF
modulates the physiology of retinal cells through the
activation of its distinct receptors (Bagnoli et al. 2003). In
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